News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ChemDiv, Inc. Announces Collaboration With Scripps Florida


10/19/2005 5:12:08 PM

SAN DIEGO, July 21 /PRNewswire/ -- ChemDiv, Inc. (ChemDiv), a global chemistry-driven contract research organization with headquarters in San Diego, California, has announced the extension of its collaboration with Palm Beach County-based Scripps Florida, the newly established division of the Scripps Research Institute of La Jolla, California.

Under the terms of the agreement, Scripps Florida is granted access to the diverse and focused screening libraries designed by ChemDiv. To support further development, ChemDiv offers synthetic, medicinal chemistry as well as its global logistics services for researchers at Scripps Florida. The financial details of the agreement were not disclosed.

Alex Kiselyov, Ph.D., Vice President of Global Chemistry, ChemDiv, stated: "We are pleased that Scripps Research has chosen to expand its relationship with ChemDiv, to support Scripps Florida. We value our long-standing association with Scripps Research, and consider it evidence of the high quality standards we strive to provide our customers."

About ChemDiv, Inc.

ChemDiv, Inc. (ChemDiv) is a global chemistry-driven contract research organization focused on scientific innovation, and the delivery of products and services that meet the drug discovery needs of its partners. ChemDiv provides its partners access to Discovery outSource(TM) a full service drug discovery capability encompassing; medicinal chemistry; pre-clinical development; synthetic chemistry; diverse and focused screening libraries, as well as global logistics. For additional information, please visit http://www.chemdiv.com.

About The Scripps Research Institute

The Scripps Research Institute, headquartered in La Jolla, California, in 14 buildings on 100 acres overlooking the Pacific Ocean, is one of the world's largest independent, non-profit biomedical research organizations. It stands at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its research into immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. Established in its current configuration in 1961, it employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel.

Scripps Florida, a 364,000 square-foot, state-of-the-art biomedical research facility, will be built in the near future in Palm Beach County. The facility will focus on basic biomedical science, drug discovery, and technology development. Palm Beach County and the State of Florida have provided start-up economic packages for development, building, staffing, and equipping the campus. Scripps Florida now operates with approximately 100 scientists, technicians, and administrative staff at 40,000 square-foot lab facilities on the Florida Atlantic University campus in Jupiter.

ChemDiv, Inc.

CONTACT: Rouslan Michtchenko, MBA, Business Development of ChemDiv, Inc.,+1-858-794-4860, or fax, +1-858-794-4931, rm@chemdiv.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES